Company Logo
Rise in the Number of Diseases are Creating a Constant Need for OTC Drugs, Medical Devices, and Diagnostics for Disease Management
OTC Drugs, Medical Devices and Diagnostics Market
OTC Drugs, Medical Devices and Diagnostics Market
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) — The “OTC Drugs, Medical Devices and Diagnostics Market” report has been added to ResearchAndMarkets.com’s offering.
The OTC Drugs, Medical Devices and Diagnostics Market was valued at USD 251.7 billion in 2024, and is expected to reach USD 359.7 billion by 2029, rising at a CAGR of 7.40%.
Report Scope
This report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics based on products and applications. Based on product, OTC drugs, medical devices, and diagnostics are categorized into OTC drugs (pharmaceutical drugs and vitamin and mineral supplements) and OTC devices and diagnostics (monitoring devices, therapeutic devices, and diagnostic devices and kits). Based on application, the report is segmented into respiratory disorders, orthopedic diseases, gastrointestinal disorders, diabetes, obesity, cardiovascular diseases, ENT disorders, skin disorders, sleep disorders, and other disorders.
The report includes:
36 data tables and 69 additional tables
An up-to-date overview of the global markets for OTC drugs, medical devices and diagnostics
Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by product type, application, and geographic region
Discussion of how the rise in the number of diseases are creating a constant need for OTC drugs, medical devices, and diagnostics for disease management
A look at the key market drivers and restraints that will shape the market for OTC drugs, medical devices, and diagnostics over the next five years (2024-2029)
A discussion on ESG challenges and practices in the industry
Review of patents issued for OTC drugs, medical devices, and diagnostics
Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews
Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
Company profiles of major players within the industry, including Haleon Group of Co., Kenvue, Sanofi, and Bayer AG
Story Continues